Precigen (PGEN) Other Non-Current Assets (2012 - 2026)

Precigen's (PGEN) quarterly Other Non-Current Assets came in at $782000.0 in Q1 2026, up 83.14% year-on-year from $427000.0 in Q1 2025, and down 13.88% on a QoQ basis from $908000.0 in Q4 2025.

Precigen (PGEN) Other Non-Current Assets (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Other Non-Current Assets data on file, last reported at $782000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 83.14% year-over-year to $782000.0 in Q1 2026; TTM through Mar 2026 was $782000.0, a 83.14% increase from a year earlier, with the FY2025 full-year figure at $908000.0, up 144.74% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $782000.0, down from $908000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PGEN reached as high as $44.3 million in Q2 2022 and fell as low as $371000.0 in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $3.5 million across 5 years, with a median of $774500.0 in 2023.
  • Across the five-year window, Other Non-Current Assets soared 402990.91% in 2022 and tumbled 97.86% in 2023, its largest moves.
  • Year by year, Other Non-Current Assets stood at $1.0 million in 2022, then slipped by 25.17% to $767000.0 in 2023, then plunged by 51.63% to $371000.0 in 2024, then jumped by 144.74% to $908000.0 in 2025, then fell by 13.88% to $782000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $782000.0 in Q1 2026, $908000.0 in Q4 2025, and $753000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn 782,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 782,000.00
Dec 31, 2025 908,000.00
Sep 30, 2025 753,000.00
Jun 30, 2025 590,000.00
Mar 31, 2025 427,000.00
Dec 31, 2024 371,000.00
Sep 30, 2024 425,000.00
Jun 30, 2024 435,000.00
Mar 31, 2024 751,000.00
Dec 31, 2023 767,000.00
Sep 30, 2023 797,000.00
Jun 30, 2023 949,000.00
Mar 31, 2023 1.00 Mn
Dec 31, 2022 1.03 Mn
Jun 30, 2022 44.34 Mn
Mar 31, 2022 1.13 Mn
Dec 31, 2021 936,000.00
Jun 30, 2021 11,000.00
Mar 31, 2021 1.43 Mn
Dec 31, 2020 1.60 Mn